\-\ Texto\\:\\ \ \(0\)\
\-\ she\\ is\\ to\\ follow\\ up\\ on\\ an\\ outpatient\\ basis\\ to\\ have\\ a\\ flexible\\ sigmoidoscopy\\ performed\\.\ \(0\)\
\-\ markedly\\ abnormal\\ appearance\\ of\\ the\\ majority\\ of\\ the\\ colon\\ consistent\\ with\\ pneumatosis\\ intestinalis\\.\\ \\ multiple\\ cystic\\ lucencies\\ are\\ present\\ diffusely\\ within\\ the\\ colonic\\ wall\\ with\\ sparing\\ of\\ the\\ distal\\ descending\\ and\\ distal\\ transverese\\ colon\\.\\ \\ cystic\\ changes\\ are\\ most\\ pronounced\\ at\\ the\\ hepatic\\ and\\ splenic\\ flexures\\.\ \(0\)\
\-\ pneumatosis\\ cystoides\\ coli\ \(0\)\
\-\ mucosal\\ disruption\ \(1\)\
\-\ \\â\\€\\¢\\ idiopathic\ \(0\)\
\-\ \\â\\€\\¢\\ trama\\ \\:\\ s\\/p\\ endoscopy\\,\\ surgery\ \(0\)\
\-\ \\â\\€\\¢\\ infection\\/inflammation\\:\\ crohn\\'s\\,\\ ulceratice\\ colitis\\,\\ c\\.\\ difficile\\ infection\\.\ \(0\)\
\-\ pulmonary\\ disease\\/process\ \(0\)\
\-\ \\â\\€\\¢\\ bronchopleural\\ fistula\ \(0\)\
\-\ \\â\\€\\¢\\ copd\\-\\ chronic\\ bronchitis\\,\\ bullous\\ lung\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ asthma\ \(0\)\
\-\ \\â\\€\\¢\\ trauma\\-\\ barotrauma\\,\\ chest\\ tube\ \(0\)\
\-\ increased\\ mucosal\\ permeability\ \(1\)\
\-\ \\â\\€\\¢\\ s\\/p\\ chemotherapy\\ or\\ radiation\ \(1\)\
\-\ \\â\\€\\¢\\ collagen\\ vascular\\ disease\ \(1\)\
\-\ other\ \(2221\)\
\-\ \\â\\€\\¢\\ gas\\ in\\ the\\ lumen\\ of\\ the\\ bowel\ \(0\)\
\-\ 33\\ y\\.o\\.\\ woman\\ with\\ a\\ history\\ of\\ mediastinal\\ b\\-cell\\ lymphoma\\ that\\ was\\ diagnosed\\ six\\ years\\ ago\\.\\ \\ she\\ has\\ received\\ chemotherapy\\ consisting\\ of\\ bleomycin\\,\\ doxyrubicin\\,\\ and\\ cytoxin\\,\\ as\\ well\\ as\\ localized\\ radiation\\.\\ \\ her\\ clinical\\ course\\ was\\ subsequently\\ complicated\\ by\\ a\\ paralyzed\\ right\\ hemi\\ diaphragm\\.\\ \\ three\\ years\\ ago\\ she\\ was\\ diagnosed\\ with\\ mac\\ and\\ treated\\ with\\ rifabutin\\ and\\ clarithromycin\\ for\\ approx\\ 3\\ years\\ with\\ persistent\\ cultures\\ after\\ 18\\ months\\ of\\ therapy\\.\\ \\ she\\ has\\ also\\ been\\ treated\\ with\\ methotrexate\\ and\\ prednisone\\ for\\ recurrent\\ episodes\\ of\\ scleritis\\ of\\ which\\ an\\ autoimmune\\ work\\ up\\ has\\ been\\ negative\\.\\ \\ \\ she\\ was\\ admitted\\ at\\ the\\ beginning\\ of\\ august\\ for\\ increased\\ cough\\ and\\ hemoptysis\\ as\\ well\\ as\\ bloody\\ diarrhea\\.\\ \\ at\\ the\\ time\\ of\\ admission\\ she\\ also\\ had\\ a\\ complaint\\ of\\ increased\\ eye\\ pain\\.\\ \\ in\\ brief\\,\\ during\\ her\\ admission\\ she\\ was\\ evaluated\\ by\\ infectious\\ disease\\ who\\ made\\ no\\ changes\\ to\\ her\\ mac\\ therapy\\ medications\\,\\ ophthalmology\\ was\\ concerned\\ for\\ worsening\\ scleritis\\ and\\ increased\\ her\\ oral\\ steroids\\ to\\ 40mg\\ qd\\,\\ cardiothoracic\\ surgery\\ who\\ discussed\\ possible\\ resection\\ of\\ her\\ damaged\\ rul\\ and\\ chronic\\ infections\\,\\ as\\ well\\ as\\ pulmonary\\ who\\ performed\\ a\\ bronchoscopy\\ to\\ obtain\\ cultures\\ as\\ well\\ as\\ to\\ localized\\ her\\ hemoptysis\\.\\ \\ no\\ evidence\\ of\\ bleeding\\ was\\ noted\\ and\\ her\\ cultures\\ of\\ the\\ rul\\ have\\ grown\\ aspergillus\\ niger\\.\\ her\\ mac\\ cultures\\ are\\ still\\ pending\\ at\\ this\\ time\\.\\ \\ she\\ was\\ also\\ evaluated\\ during\\ this\\ admission\\ by\\ gi\\ for\\ her\\ diarrhea\\ and\\ her\\ incidental\\ finding\\ of\\ pneumatosis\\ cystoides\\ coli\\.\ \(0\)\
\-\ the\\ exact\\ time\\ of\\ onset\\ of\\ this\\ patient\\â\\€\\™s\\ pneumatosis\\ is\\ not\\ clear\\.\\ \\ while\\ literature\\ case\\ studies\\ do\\ report\\ an\\ association\\ of\\ pneumatosis\\ intestinalis\\ with\\ chemotheraputic\\ agents\\ such\\ at\\ etoposide\\,\\ this\\ drug\\ was\\ not\\ included\\ in\\ her\\ treatment\\ regimen\\.\\ further\\ investigation\\ of\\ her\\ medical\\ imaging\\ and\\ medication\\ history\\ would\\ be\\ useful\\ to\\ identify\\ the\\ time\\ of\\ onset\\ in\\ order\\ to\\ attempt\\ to\\ correlate\\ these\\ findings\\ with\\ a\\ specific\\ medication\\ of\\ other\\ medical\\ intervention\\.\\ \\ a\\ pubmed\\ mesh\\ literature\\ search\\ for\\ mac\\ associated\\ pneumatosis\\ intestinalis\\ did\\ not\\ produce\\ any\\ results\\.\\ \\ while\\ she\\ does\\ complain\\ of\\ diarrhea\\,\\ obviously\\ a\\ very\\ nonspecific\\ symptom\\,\\ she\\ does\\ not\\ display\\ a\\ clinical\\ appearance\\ or\\ evidence\\ of\\ an\\ intraabdominal\\ catastrophe\\.\\ \\ therefore\\,\\ she\\ most\\ likely\\ suffers\\ from\\ a\\ benign\\ course\\ of\\ pneumatosis\\ intestinalis\\ and\\ should\\ only\\ be\\ treated\\ if\\ she\\ becomes\\ significantly\\ symptomatic\\.\\ \\ treatment\\ options\\,\\ outlined\\ in\\ the\\ topic\\ introduction\\,\\ include\\ high\\-flow\\ oxygen\\ therapy\\,\\ hyperbaric\\ oxygen\\ therapy\\,\\ antibiotics\\ and\\ special\\ diets\\.\ \(0\)\
\-\ goldberg\\,\\ e\\.\\,\\ lamont\\,\\ jt\\.\\ \\(2009\\)\\.\\ pneumatosis\\ intestinalis\\.\\ in\\ b\\.\\ rose\\ \\(ed\\.\\)\\,uptodate\\.\\ available\\ from\\ http\\:\\/\\/www\\.uptodateonline\\.com\\.\\ \ \(0\)\
\-\ emedicine\\.\\ pneumatosis\\ intestinalis\\.\\(n\\.d\\)\\.retrieved\\ july\\ 10\\,\\ 2009\\,\\ from\\ http\\:\\/\\/emedicine\\.medscape\\.com\\/article\\/371955\\-overview\ \(0\)\
\-\ hashimoto\\,\\ s\\.\\,\\ hiroyuki\\,\\ s\\.\\,\\ wada\\,\\ k\\.\\,\\ kobayashi\\,\\ t\\.\\,\\ hiroshi\\,\\ f\\.\\,\\ hirokazu\\,\\ k\\.\\,\\ et\\ al\\.\\ \\(1995\\)\\.\\ pneumatosis\\ cystoides\\ intestinalis\\ after\\ chemotherapy\\ for\\ hematological\\ malignancies\\:\\ report\\ of\\ 4\\ cases\\.\\ internal\\ medicine\\ 34\\,\\ 212\\-215\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pneumatosis\\:\\ 0\\.08099782387979076\ \(0\)\
\-\ intestinalis\\:\\ 0\\.06293653309892865\ \(0\)\
\-\ her\\:\\ 0\\.047217365852709386\ \(0\)\
\-\ mac\\:\\ 0\\.045508263784665284\ \(0\)\
\-\ she\\:\\ 0\\.04408182802059735\ \(0\)\
\-\ cystoides\\:\\ 0\\.03310603604073077\ \(0\)\
\-\ scleritis\\:\\ 0\\.02700005642868759\ \(0\)\
\-\ cultures\\:\\ 0\\.026932176515588976\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.02399715699228006\ \(0\)\
\-\ diarrhea\\:\\ 0\\.020368262431665927\ \(0\)\
\-\ rul\\:\\ 0\\.018508207355977694\ \(0\)\
\-\ k\\.\\:\\ 0\\.018322527044135627\ \(0\)\
\-\ coli\\:\\ 0\\.0179818665996939\ \(0\)\
\-\ admission\\:\\ 0\\.017300133614319885\ \(0\)\
\-\ 2009\\:\\ 0\\.016686746076508496\ \(0\)\
\-\ \\,\\:\\ 0\\.016167982473467395\ \(0\)\
\-\ as\\:\\ 0\\.015835559030862208\ \(0\)\
\-\ s\\.\\:\\ 0\\.015341059522806061\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.015080239282866375\ \(0\)\
\-\ oxygen\\:\\ 0\\.015018362690775963\ \(0\)\
\-\ time\\:\\ 0\\.01478469358186409\ \(0\)\
\-\ literature\\:\\ 0\\.01407660250778068\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01407172642484318\ \(0\)\
\-\ therapy\\:\\ 0\\.013994736883556588\ \(0\)\
\-\ was\\:\\ 0\\.013620976569560767\ \(0\)\
\-\ mucosal\\:\\ 0\\.013503213404907335\ \(0\)\
\-\ transverese\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ trama\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ ulceratice\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ disease\\/process\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ copd\\-\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ trauma\\-\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ cytoxin\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ rifabutin\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ chemotheraputic\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ catastrophe\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ high\\-flow\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ lamont\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ \\/\\/www\\.uptodateonline\\.com\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ \\.retrieved\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ \\/\\/emedicine\\.medscape\\.com\\/article\\/371955\\-overview\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ hiroyuki\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ kobayashi\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ hiroshi\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ hirokazu\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ 212\\-215\\:\\ 0\\.013500028214343795\ \(0\)\
\-\ medication\\:\\ 0\\.01318425395849816\ \(0\)\
\-\ increased\\:\\ 0\\.012805419796628826\ \(0\)\
\-\ localized\\:\\ 0\\.012745966535402681\ \(0\)\
\-\ paralyzed\\:\\ 0\\.012438547080255059\ \(0\)\
\-\ niger\\:\\ 0\\.012438547080255059\ \(0\)\
\-\ wada\\:\\ 0\\.012438547080255059\ \(0\)\
\-\ evaluated\\:\\ 0\\.011999015693769025\ \(0\)\
\-\ well\\:\\ 0\\.01184123095233477\ \(0\)\
\-\ sigmoidoscopy\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ flexures\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ infection\\/inflammation\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ doxyrubicin\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ clarithromycin\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ diets\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ goldberg\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ hematological\\:\\ 0\\.011817620421590182\ \(0\)\
\-\ treated\\:\\ 0\\.011751228955974852\ \(0\)\
\-\ report\\:\\ 0\\.011715423697359149\ \(0\)\
\-\ years\\:\\ 0\\.01152791640284142\ \(0\)\
\-\ permeability\\:\\ 0\\.011377065946166321\ \(0\)\
\-\ 40mg\\:\\ 0\\.011377065946166321\ \(0\)\
\-\ rose\\:\\ 0\\.011377065946166321\ \(0\)\
\-\ bullous\\:\\ 0\\.011035345346910258\ \(0\)\
\-\ bleomycin\\:\\ 0\\.011035345346910258\ \(0\)\
\-\ hemi\\:\\ 0\\.011035345346910258\ \(0\)\
\-\ s\\/p\\:\\ 0\\.010978284248428519\ \(0\)\
\-\ bronchopleural\\:\\ 0\\.010756139287501444\ \(0\)\
\-\ mesh\\:\\ 0\\.010756139287501444\ \(0\)\
\-\ hyperbaric\\:\\ 0\\.010756139287501444\ \(0\)\
\-\ flexible\\:\\ 0\\.010520073927888491\ \(0\)\
\-\ barotrauma\\:\\ 0\\.010520073927888491\ \(0\)\
\-\ introduction\\:\\ 0\\.010520073927888491\ \(0\)\
\-\ n\\.d\\:\\ 0\\.010520073927888491\ \(0\)\
\-\ etoposide\\:\\ 0\\.010315584812077585\ \(0\)\
\-\ obviously\\:\\ 0\\.010315584812077585\ \(0\)\
\-\ jt\\:\\ 0\\.010315584812077585\ \(0\)\
\-\ colon\\:\\ 0\\.010278508146469646\ \(0\)\
\-\ who\\:\\ 0\\.010235689475383012\ \(0\)\
\-\ difficile\\:\\ 0\\.010135212628836567\ \(0\)\
\-\ pubmed\\:\\ 0\\.010135212628836567\ \(0\)\
\-\ cardiothoracic\\:\\ 0\\.00997386421282152\ \(0\)\
\-\ suffers\\:\\ 0\\.00997386421282152\ \(0\)\
\-\ http\\:\\ 0\\.009910531693660875\ \(0\)\
\-\ course\\:\\ 0\\.00987605342559155\ \(0\)\
\-\ ago\\:\\ 0\\.009741895316377485\ \(0\)\
\-\ aspergillus\\:\\ 0\\.009694658153412708\ \(0\)\
\-\ uptodate\\:\\ 0\\.009694658153412708\ \(0\)\
\-\ diagnosed\\:\\ 0\\.009623874905957138\ \(0\)\
\-\ grown\\:\\ 0\\.009572081265704382\ \(0\)\
\-\ intraabdominal\\:\\ 0\\.009572081265704382\ \(0\)\
\-\ bronchitis\\:\\ 0\\.009458592793799755\ \(0\)\
\-\ damaged\\:\\ 0\\.009458592793799755\ \(0\)\
\-\ hashimoto\\:\\ 0\\.009458592793799755\ \(0\)\
\-\ outlined\\:\\ 0\\.009352937554156643\ \(0\)\
\-\ display\\:\\ 0\\.009254103677988847\ \(0\)\
\-\ emedicine\\:\\ 0\\.009254103677988847\ \(0\)\
\-\ t\\.\\:\\ 0\\.009073731494747831\ \(0\)\
\-\ brief\\:\\ 0\\.00899093329984695\ \(0\)\
\-\ does\\:\\ 0\\.008929926708679958\ \(0\)\
\-\ at\\:\\ 0\\.008864955228419855\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.008837666135134878\ \(0\)\
\-\ investigation\\:\\ 0\\.008837666135134878\ \(0\)\
\-\ concerned\\:\\ 0\\.008766425682401505\ \(0\)\
\-\ \\:\\:\\ 0\\.00865447791723327\ \(0\)\
\-\ qd\\:\\ 0\\.00863317701932397\ \(0\)\
\-\ radiation\\:\\ 0\\.008588824654095977\ \(0\)\
\-\ approx\\:\\ 0\\.008510600131615644\ \(0\)\
\-\ search\\:\\ 0\\.008510600131615644\ \(0\)\
\-\ special\\:\\ 0\\.008510600131615644\ \(0\)\
\-\ f\\.\\:\\ 0\\.008510600131615644\ \(0\)\
\-\ bloody\\:\\ 0\\.008452804836082954\ \(0\)\
\-\ july\\:\\ 0\\.008452804836082954\ \(0\)\
\-\ methotrexate\\:\\ 0\\.008343373038254248\ \(0\)\
\-\ autoimmune\\:\\ 0\\.008343373038254248\ \(0\)\
\-\ malignancies\\:\\ 0\\.008343373038254248\ \(0\)\
\-\ pronounced\\:\\ 0\\.008291456420067907\ \(0\)\
\-\ obtain\\:\\ 0\\.008291456420067907\ \(0\)\
\-\ onset\\:\\ 0\\.008261627031930016\ \(0\)\
\-\ consisting\\:\\ 0\\.008241242296296098\ \(0\)\
\-\ while\\:\\ 0\\.00823476030582638\ \(0\)\
\-\ regimen\\:\\ 0\\.008192622543900109\ \(0\)\
\-\ complain\\:\\ 0\\.008192622543900109\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.008145499023736628\ \(0\)\
\-\ beginning\\:\\ 0\\.008145499023736628\ \(0\)\
\-\ correlate\\:\\ 0\\.008145499023736628\ \(0\)\
\-\ exact\\:\\ 0\\.008099782387979076\ \(0\)\
\-\ 1995\\:\\ 0\\.008099782387979076\ \(0\)\
\-\ august\\:\\ 0\\.008055391060454954\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.008055391060454954\ \(0\)\
\-\ clinical\\:\\ 0\\.00805301623297398\ \(0\)\
\-\ medical\\:\\ 0\\.00805301623297398\ \(0\)\
\-\ during\\:\\ 0\\.008009216691956533\ \(0\)\
\-\ e\\.\\:\\ 0\\.007929452165758213\ \(0\)\
\-\ basis\\:\\ 0\\.007850901944644046\ \(0\)\
\-\ lucencies\\:\\ 0\\.007850901944644046\ \(0\)\
\-\ for\\:\\ 0\\.007815860705205216\ \(0\)\
\-\ identify\\:\\ 0\\.007813087836542405\ \(0\)\
\-\ sparing\\:\\ 0\\.00777618500104614\ \(0\)\
\-\ b\\.\\:\\ 0\\.00777618500104614\ \(0\)\
\-\ prednisone\\:\\ 0\\.007740150548656869\ \(0\)\
\-\ also\\:\\ 0\\.007739446831562718\ \(0\)\
\-\ agents\\:\\ 0\\.007670529761403031\ \(0\)\
\-\ pulmonary\\:\\ 0\\.007646402175252875\ \(0\)\
\-\ endoscopy\\:\\ 0\\.007571695885235234\ \(0\)\
\-\ c\\.\\:\\ 0\\.007571695885235234\ \(0\)\
\-\ not\\:\\ 0\\.0075639734869337545\ \(0\)\
\-\ cystic\\:\\ 0\\.0075486453514602096\ \(0\)\
\-\ attempt\\:\\ 0\\.007509181345387981\ \(0\)\
\-\ changes\\:\\ 0\\.007500912637779665\ \(0\)\
\-\ appearance\\:\\ 0\\.0074851656255272335\ \(0\)\
\-\ outpatient\\:\\ 0\\.007449118997526908\ \(0\)\
\-\ collagen\\:\\ 0\\.007449118997526908\ \(0\)\
\-\ symptom\\:\\ 0\\.007419948714263977\ \(0\)\
\-\ has\\:\\ 0\\.0073722816408619204\ \(0\)\
\-\ chronic\\:\\ 0\\.007372096884860643\ \(0\)\
\-\ performed\\:\\ 0\\.007297330264095923\ \(0\)\
\-\ produce\\:\\ 0\\.007255713598867962\ \(0\)\
\-\ an\\:\\ 0\\.007238375891483797\ \(0\)\
\-\ asthma\\:\\ 0\\.0072299752859791705\ \(0\)\
\-\ colitis\\:\\ 0\\.007179761162207361\ \(0\)\
\-\ discussed\\:\\ 0\\.007155258342381265\ \(0\)\
\-\ colonic\\:\\ 0\\.007131141409811372\ \(0\)\
\-\ been\\:\\ 0\\.007120351881972408\ \(0\)\
\-\ distal\\:\\ 0\\.007115707776251231\ \(0\)\
\-\ splenic\\:\\ 0\\.007084017889647891\ \(0\)\
\-\ diaphragm\\:\\ 0\\.00703830125389034\ \(0\)\
\-\ up\\:\\ 0\\.007037816695418754\ \(0\)\
\-\ crohn\\:\\ 0\\.006993909926366216\ \(0\)\
\-\ topic\\:\\ 0\\.006950769226570357\ \(0\)\
\-\ evidence\\:\\ 0\\.006861998723941433\ \(0\)\
\-\ becomes\\:\\ 0\\.006847952530034938\ \(0\)\
\-\ useful\\:\\ 0\\.006828192338862032\ \(0\)\
\-\ 33\\:\\ 0\\.006789420810555309\ \(0\)\
\-\ complicated\\:\\ 0\\.006789420810555309\ \(0\)\
\-\ nonspecific\\:\\ 0\\.006733044128897244\ \(0\)\
\-\ drug\\:\\ 0\\.006714703866957403\ \(0\)\
\-\ significantly\\:\\ 0\\.006696580654634275\ \(0\)\
\-\ diffusely\\:\\ 0\\.006609048627314294\ \(0\)\
\-\ order\\:\\ 0\\.006558834503542484\ \(0\)\
\-\ by\\:\\ 0\\.0065369260485982\ \(0\)\
\-\ 34\\:\\ 0\\.006494345245732183\ \(0\)\
\-\ episodes\\:\\ 0\\.006463091230983015\ \(0\)\
\-\ majority\\:\\ 0\\.006432462338629768\ \(0\)\
\-\ six\\:\\ 0\\.006432462338629768\ \(0\)\
\-\ fistula\\:\\ 0\\.006417374595225463\ \(0\)\
\-\ disease\\:\\ 0\\.006416864661021612\ \(0\)\
\-\ descending\\:\\ 0\\.0063876378634381715\ \(0\)\
\-\ disruption\\:\\ 0\\.006372983267701341\ \(0\)\
\-\ association\\:\\ 0\\.00635846758017524\ \(0\)\
\-\ options\\:\\ 0\\.00635846758017524\ \(0\)\
\-\ surgery\\:\\ 0\\.0063552804421447935\ \(0\)\
\-\ lumen\\:\\ 0\\.006301742814967966\ \(0\)\
\-\ gas\\:\\ 0\\.0062336696716741935\ \(0\)\
\-\ still\\:\\ 0\\.0062336696716741935\ \(0\)\
\-\ infections\\:\\ 0\\.006220410770076775\ \(0\)\
\-\ medicine\\:\\ 0\\.006207265680197155\ \(0\)\
\-\ markedly\\:\\ 0\\.006194232464779224\ \(0\)\
\-\ therefore\\:\\ 0\\.00618130923561251\ \(0\)\
\-\ steroids\\:\\ 0\\.006155785418636688\ \(0\)\
\-\ work\\:\\ 0\\.006130680043788791\ \(0\)\
\-\ received\\:\\ 0\\.006081671267240287\ \(0\)\
\-\ a\\:\\ 0\\.006073503856333863\ \(0\)\
\-\ complaint\\:\\ 0\\.006045917264182107\ \(0\)\
\-\ most\\:\\ 0\\.006042374094113556\ \(0\)\
\-\ included\\:\\ 0\\.0060341823901460135\ \(0\)\
\-\ other\\:\\ 0\\.006032583610114698\ \(0\)\
\-\ idiopathic\\:\\ 0\\.005965601069124615\ \(0\)\
\-\ subsequently\\:\\ 0\\.00593242879227748\ \(0\)\
\-\ this\\:\\ 0\\.005887517386304031\ \(0\)\
\-\ to\\:\\ 0\\.005886084189872705\ \(0\)\
\-\ gi\\:\\ 0\\.005878690170820711\ \(0\)\
\-\ medications\\:\\ 0\\.00583701702606591\ \(0\)\
\-\ intervention\\:\\ 0\\.005826773552634368\ \(0\)\
\-\ from\\:\\ 0\\.0058182345167881126\ \(0\)\
\-\ 18\\:\\ 0\\.00568081615630309\ \(0\)\
\-\ bleeding\\:\\ 0\\.00568081615630309\ \(0\)\
\-\ do\\:\\ 0\\.00568081615630309\ \(0\)\
\-\ have\\:\\ 0\\.005667497942925243\ \(0\)\
\-\ pending\\:\\ 0\\.005662365408192563\ \(0\)\
\-\ admitted\\:\\ 0\\.005653222732868666\ \(0\)\
\-\ infectious\\:\\ 0\\.005626117714339722\ \(0\)\
\-\ mediastinal\\:\\ 0\\.0055560989557821485\ \(0\)\
\-\ al\\:\\ 0\\.005547567493225556\ \(0\)\
\-\ ed\\:\\ 0\\.005530645845160342\ \(0\)\
\-\ recurrent\\:\\ 0\\.005522254626531512\ \(0\)\
\-\ tube\\:\\ 0\\.00551390913684152\ \(0\)\
\-\ oral\\:\\ 0\\.00551390913684152\ \(0\)\
\-\ eye\\:\\ 0\\.005489142124214259\ \(0\)\
\-\ hepatic\\:\\ 0\\.005464769298324674\ \(0\)\
\-\ after\\:\\ 0\\.005415011340303836\ \(0\)\
\-\ specific\\:\\ 0\\.00540936400494412\ \(0\)\
\-\ et\\:\\ 0\\.005355893461136726\ \(0\)\
\-\ are\\:\\ 0\\.00535164106828301\ \(0\)\
\-\ treatment\\:\\ 0\\.0052974485745815834\ \(0\)\
\-\ results\\:\\ 0\\.005282607058108188\ \(0\)\
\-\ persistent\\:\\ 0\\.005219520141663675\ \(0\)\
\-\ made\\:\\ 0\\.005212668257444806\ \(0\)\
\-\ symptomatic\\:\\ 0\\.005199055780542438\ \(0\)\
\-\ worsening\\:\\ 0\\.005152342986831237\ \(0\)\
\-\ cough\\:\\ 0\\.005014172861880662\ \(0\)\
\-\ incidental\\:\\ 0\\.004955265846830438\ \(0\)\
\-\ antibiotics\\:\\ 0\\.0049153389857128655\ \(0\)\
\-\ studies\\:\\ 0\\.0048874439782222966\ \(0\)\
\-\ clear\\:\\ 0\\.004838478733762091\ \(0\)\
\-\ very\\:\\ 0\\.004750054545876155\ \(0\)\
\-\ did\\:\\ 0\\.004724990261857464\ \(0\)\
\-\ would\\:\\ 0\\.00465691711856369\ \(0\)\
\-\ of\\:\\ 0\\.0046387424513747305\ \(0\)\
\-\ benign\\:\\ 0\\.004516156764216235\ \(0\)\
\-\ \\(\\:\\ 0\\.004424880405781688\ \(0\)\
\-\ three\\:\\ 0\\.004411369415538913\ \(0\)\
\-\ 10\\:\\ 0\\.004411369415538913\ \(0\)\
\-\ possible\\:\\ 0\\.004407323459240539\ \(0\)\
\-\ available\\:\\ 0\\.004399263474486673\ \(0\)\
\-\ internal\\:\\ 0\\.004387252482969022\ \(0\)\
\-\ \\)\\:\\ 0\\.004370828129331119\ \(0\)\
\-\ cases\\:\\ 0\\.0043595878468317495\ \(0\)\
\-\ vascular\\:\\ 0\\.004290663503711633\ \(0\)\
\-\ finding\\:\\ 0\\.004217552075097215\ \(0\)\
\-\ should\\:\\ 0\\.004171835439339663\ \(0\)\
\-\ further\\:\\ 0\\.004161476480551697\ \(0\)\
\-\ follow\\:\\ 0\\.004158039007574938\ \(0\)\
\-\ any\\:\\ 0\\.004120727462591568\ \(0\)\
\-\ bowel\\:\\ 0\\.004104063603192587\ \(0\)\
\-\ such\\:\\ 0\\.0040908618527425\ \(0\)\
\-\ resection\\:\\ 0\\.0040810346945179465\ \(0\)\
\-\ be\\:\\ 0\\.004036008341022754\ \(0\)\
\-\ only\\:\\ 0\\.003934780487725782\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.003911220121968539\ \(0\)\
\-\ negative\\:\\ 0\\.0039083004002678015\ \(0\)\
\-\ in\\:\\ 0\\.0038719500472305206\ \(0\)\
\-\ and\\:\\ 0\\.0038593048702160156\ \(0\)\
\-\ infection\\:\\ 0\\.003804007004705677\ \(0\)\
\-\ wall\\:\\ 0\\.003790442756874037\ \(0\)\
\-\ lung\\:\\ 0\\.003790442756874037\ \(0\)\
\-\ y\\.o\\:\\ 0\\.003776997599673354\ \(0\)\
\-\ s\\:\\ 0\\.0037530898424419407\ \(0\)\
\-\ lymphoma\\:\\ 0\\.003739967280841479\ \(0\)\
\-\ abnormal\\:\\ 0\\.003732147381799252\ \(0\)\
\-\ likely\\:\\ 0\\.0036911025512031495\ \(0\)\
\-\ include\\:\\ 0\\.0036709854334307608\ \(0\)\
\-\ 4\\:\\ 0\\.0036462050615299318\ \(0\)\
\-\ history\\:\\ 0\\.0036147459041564575\ \(0\)\
\-\ months\\:\\ 0\\.003574182687121083\ \(0\)\
\-\ if\\:\\ 0\\.0035509087806747863\ \(0\)\
\-\ these\\:\\ 0\\.0034055814578221135\ \(0\)\
\-\ consistent\\:\\ 0\\.0032087262922376775\ \(0\)\
\-\ chest\\:\\ 0\\.003131284839291759\ \(0\)\
\-\ noted\\:\\ 0\\.0031017169807849828\ \(0\)\
\-\ associated\\:\\ 0\\.0030879977977147045\ \(0\)\
\-\ or\\:\\ 0\\.0030674509922318763\ \(0\)\
\-\ imaging\\:\\ 0\\.003065962977726804\ \(0\)\
\-\ 3\\:\\ 0\\.003064281051617978\ \(0\)\
\-\ woman\\:\\ 0\\.003022822277930944\ \(0\)\
\-\ present\\:\\ 0\\.0029556029922384085\ \(0\)\
\-\ \\'s\\:\\ 0\\.0028852168734564243\ \(0\)\
\-\ case\\:\\ 0\\.0028629470641152693\ \(0\)\
\-\ had\\:\\ 0\\.0028236597538142546\ \(0\)\
\-\ findings\\:\\ 0\\.0027853551849769675\ \(0\)\
\-\ multiple\\:\\ 0\\.002756211337640534\ \(0\)\
\-\ the\\:\\ 0\\.002752282850148752\ \(0\)\
\-\ no\\:\\ 0\\.0026353572762750446\ \(0\)\
\-\ within\\:\\ 0\\.0024963727540368787\ \(0\)\
\-\ which\\:\\ 0\\.002442794161167762\ \(0\)\
\-\ that\\:\\ 0\\.0022603073944239254\ \(0\)\
\-\ \\.\\:\\ 0\\.0019570954050604377\ \(0\)\
\-\ is\\:\\ 0\\.0017221769628934936\ \(0\)\
\-\ with\\:\\ 0\\.0016126149843935797\ \(0\)\
\-\ pain\\:\\ 0\\.0015981748354222584\ \(0\)\
\-\ right\\:\\ 0\\.0013807530001690915\ \(0\)\
\-\ patient\\:\\ 0\\.0013117793735319878\ \(0\)\
\-\ on\\:\\ 0\\.001108562040375847\ \(0\)\
